New Normal Labs ApS: Financial statements 2024
CVR: 39733560
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
New Normal Labs ApS (CVR 39733560) has filed annual accounts for 2024. In 2024, the company reported a net result of DKK -7,022 compared with DKK -17,630 the year before. Equity in the 2024 report amounted to DKK 11,674. The solvency ratio was 4.5%.
- Profit/Loss
- DKK -7,022
- Equity
- DKK 11,674
- Total Assets
- DKK 257,075
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | -7 t. | 12 t. | - |
| 2023 | - | -17 t. | -18 t. | 19 t. | - |
| 2022 | - | 33 t. | 32 t. | 36 t. | - |
| 2021 | - | -19 t. | -20 t. | 4 t. | - |
| 2020 | - | - | 6 t. | -17 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
New Normal Labs ApS has published its annual report for 2023. Gross profit came to DKK -17,337, and the net result was DKK -17,630.
About New Normal Labs ApS
New Normal Labs ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2018. The company is registered under the industry Undervisning inden for sport og fritid. The management consists of Martin Kremmer. In 2025, the company reported a gross profit of DKK -1,868 and a net result of DKK -3,283 compared with DKK -7,022 the year before. Equity in the 2025 report amounted to DKK 8,391.